Management of Severe Asthma Beyond the Guidelines

• Published in: Current allergy and asthma reports 2020-09, Vol.20 (9), p.47-47, Article 47
• Main Authors: Reihman, Anne E., Holguin, Fernando, Sharma, Sunita
• Format: Article
• Language: English
• Subjects: Allergology; Asthma; Asthma (V Ortega; Asthma - therapy; Complex patients; Disease; Guidelines as Topic; Humans; Medicine; Medicine & Public Health; Section Editor; Topical Collection on Asthma
• ISSN: 1529-7322; 1534-6315
• DOI: 10.1007/s11882-020-00940-6

Purpose of Review Asthma is one of the most common chronic respiratory diseases worldwide, yet only a small percentage of patients are categorized as having severe disease. Severe asthmatics, however, are responsible for the largest burden of healthcare costs and lost productivity. Several recent guidelines have addressed disease pathogenesis and treatment modalities for these complex patients. Herein, we review the severe asthma guidelines, compare the existing guidelines, address key areas that are yet to be addressed in the guidelines, and discuss future directions for severe asthma research. Recent Findings This is a narrative review of the 2019 European Respiratory Society/American Thoracic Society (ERS/ATS) and Global Initiative for Asthma (GINA) guidelines that specifically address the diagnosis and management of severe asthma. The pathophysiological mechanisms that underlie severe asthma are reviewed, and novel therapies that target specific pathophysiological pathways in severe asthma are discussed in detail. Although the guidelines address the use of novel biological therapies for patients with T2-mediated disease, data comparing these agents remain sparse. This review addresses several areas that are topics beyond the guidelines and highlight key areas where future research is warranted. Summary This review provides a comprehensive overview of the current state of severe asthma treatment and discusses potential avenues for future research for this patient population.